Clinical Trial: Comparative Study of CMAB015 and Secukinumab for Patients With Moderate to Severe Plaque Psoriasis

U.S., May 3 -- ClinicalTrials.gov registry received information related to the study (NCT06398652) titled 'Comparative Study of CMAB015 and Secukinumab for Patients With Moderate to Severe Plaque Psoriasis' on May 1.

Brief Summary: The goal of this trial is to assess whether the efficacy of CMAB015 is similar to that of Secukinumab in patients with moderate-severe chronic plaque psoriasis. It will also learn about the similarity of CMAB015 and Secukinumab in terms of safety and immunogenicity in patients with moderate-severe chronic plaque psoriasis. The main question it aims to answer is:

In subjects with moderate to severe plate psoriasis treated with CMAB015, Is the proportion of patients achieving a 75% improvement in PASI (Psoriasis ...